1. Home
  2. GRC vs NBTX Comparison

GRC vs NBTX Comparison

Compare GRC & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gorman-Rupp Company (The)

GRC

Gorman-Rupp Company (The)

HOLD

Current Price

$49.55

Market Cap

1.2B

Sector

Industrials

ML Signal

HOLD

Logo Nanobiotix S.A.

NBTX

Nanobiotix S.A.

HOLD

Current Price

$22.91

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRC
NBTX
Founded
1933
2003
Country
United States
France
Employees
N/A
N/A
Industry
Fluid Controls
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.0B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
GRC
NBTX
Price
$49.55
$22.91
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$8.00
AVG Volume (30 Days)
91.0K
50.1K
Earning Date
10-24-2025
09-30-2025
Dividend Yield
1.53%
N/A
EPS Growth
31.51
N/A
EPS
1.91
N/A
Revenue
$678,522,000.00
$11,930,711.00
Revenue This Year
$4.94
N/A
Revenue Next Year
$4.02
$136.64
P/E Ratio
$25.93
N/A
Revenue Growth
3.19
N/A
52 Week Low
$30.87
$2.82
52 Week High
$49.90
$30.35

Technical Indicators

Market Signals
Indicator
GRC
NBTX
Relative Strength Index (RSI) 73.09 57.57
Support Level $45.80 $20.83
Resistance Level $46.94 $23.77
Average True Range (ATR) 1.15 0.88
MACD 0.45 0.17
Stochastic Oscillator 96.46 77.16

Price Performance

Historical Comparison
GRC
NBTX

About GRC Gorman-Rupp Company (The)

Gorman-Rupp Co designs, manufactures, and globally sells pumps & pump systems for use in water, wastewater, construction, dewatering, industrial, petroleum, original equipment, agriculture, fire protection, heating, ventilating & air conditioning, military, and other liquid-handling applications. It operates in one business segment, the manufacture & sale of pumps and pump systems, and generates revenue from the same. Geographically, it generates the majority of revenue from the United States.

About NBTX Nanobiotix S.A.

Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.

Share on Social Networks: